We are live on
!
Find out more
FLXN
Flexion Therapeutics, Inc.
FLXN
FLXN
Delisted
FLXN was delisted on the 18th of November, 2021.
130 hedge funds and large institutions have $973M invested in Flexion Therapeutics, Inc. in 2018 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 46 increasing their positions, 39 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
189% more call options, than puts
Call options by funds: $11.9M | Put options by funds: $4.12M
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
18% more capital invested
Capital invested by funds: $823M → $973M (+$150M)
18% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 39
3% less funds holding
Funds holding: 134 → 130 (-4)
20% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 20
Holders
130
Holders Change
-4
Holders Change %
-2.99%
% of All Funds
2.98%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.09%
New
16
Increased
46
Reduced
39
Closed
20
Calls
$11.9M
Puts
$4.12M
Net Calls
+$7.79M
Net Calls Change
+$2.19M
Top Buyers
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$14.1M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$6.4M |
| 3 |
ZDA
Zweig-DiMenna Associates
New York
|
+$5.79M |
| 4 |
BlackRock
New York
|
+$5.64M |
| 5 |
CC
Clearline Capital
New York
|
+$5.43M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$18M |
| 2 |
State Street
Boston,
Massachusetts
|
-$7.44M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$6.45M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$4.08M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.24M |
